The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Stimulation of anti-tumor immunity by photodynamic therapy
Open accessAbstract
Photodynamic therapy (PDT) is a rapidly developing cancer treatment that utilizes the combination of nontoxic dyes and harmless visible light to destroy tumors by generating reactive oxygen species. PDT produces tumor-cell destruction in the context of acute inflammation that acts as a 'danger signal' to the innate immune system. Activation of the innate immune system increases the priming of tumor-specific T lymphocytes that have the ability to recognize and destroy distant tumor cells and, in addition, lead to the development of an immune memory that can combat recurrence of the cancer at a later point in time. PDT may be also successfully combined with immunomodulating strategies that are capable of overcoming or bypassing the escape mechanisms employed by the progressing tumor to evade immune attack. This article will cover the role of the immune response in PDT anti-tumor effectiveness. It will highlight the milestones in the development of PDT-mediated anti-tumor immunity and emphasize the combination strategies that may improve this therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., & Peng, Q. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.889 · Cited by 4,716
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Gomer, C. J. (1988) · Cited by 4,169
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Photodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
Self-citationWiklund, R. A., & Rosenbaum, S. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371606 · Cited by 2,149
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430107 · Cited by 1,666
The role of apoptosis in response to photodynamic therapy: what, where, why, and how
Oleinick, N. L., Morris, R. L., & Belichenko, I. (2002) · Photochemical & Photobiological Sciences · doi:10.1039/b108586g · Cited by 1,503
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION
Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H.-H., Brown, G. D., & Gordon, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115816 · Cited by 1,324
Singlet oxygen: there is indeed something new under the sun
Ogilby, P. R. (2010) · Chemical Society Reviews · doi:10.1039/b926014p · Cited by 1,266
Seong, S.-Y., & Matzinger, P. (2004) · Nature Reviews Immunology · doi:10.1038/nri1372 · Cited by 1,220
Robertson, C. A., Evans, D. H., & Abrahamse, H. (2009) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2009.04.001 · Cited by 1,198
Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy
Detty, M. R., Gibson, S. L., & Wagner, S. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040074b · Cited by 1,045
The natural history of cervical HPV infection: unresolved issues
Woodman, C. B. J., Collins, S. I., & Young, L. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2050 · Cited by 1,033
TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
Marie, J. C., Letterio, J. J., Gavin, M., & Rudensky, A. Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042276 · Cited by 985
Fontenot, J. D., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1179 · Cited by 950
Brichard, V, Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., & Boon, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.489 · Cited by 950
Ziegler, S. F. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090547 · Cited by 922
State of the art in the delivery of photosensitizers for photodynamic therapy
Konan, Y. N., Gurny, R., & Allémann, E. (2002) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00267-6 · Cited by 906
Coulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnotte, B., & Martin, F. (2004) · European Journal of Immunology · doi:10.1002/eji.200324181 · Cited by 880
Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., & Zitvogel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050463 · Cited by 776
Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., & Boon, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.921 · Cited by 762
Mincle is an ITAM-coupled activating receptor that senses damaged cells
Yamasaki, S., Ishikawa, E., Sakuma, M., Hara, H., Ogata, K., & Saito, T. (2008) · Nature Immunology · doi:10.1038/ni.1651 · Cited by 740
Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
Van den Eynde, B. J., & van der Bruggen, P. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80050-7 · Cited by 623
Bakker, A. B., Schreurs, M. W., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., & Figdor, C. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.1005 · Cited by 589
Girotti, A. W. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00207-x · Cited by 574
Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., & Boon, T. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.689 · Cited by 567
Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1185 · Cited by 550
T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis
Critchfield, J. M., Racke, M. K., Zúñiga-Pflücker, J. C., Cannella, B., Raine, C. S., Goverman, J., & Lenardo, M. J. (1994) · Science · doi:10.1126/science.7509084 · Cited by 524
High-mobility group box 1 and cancer
Tang, D., Kang, R., Zeh III, H. J., & Lotze, M. T. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.014 · Cited by 512
Stephens, G. L., McHugh, R. S., Whitters, M. J., Young, D. A., Luxenberg, D., Carreno, B. M., Collins, M., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5008 · Cited by 499
Structure and Biodistribution Relationships of Photodynamic Sensitizers*
Boyle, R. W., & Dolphin, D. (1996) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1996.tb03093.x · Cited by 498
Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation
Garg, A. D., Nowis, D., Golab, J., Vandenabeele, P., Krysko, D. V., & Agostinis, P. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.08.003 · Cited by 496
Molecular characteristics of immunogenic cancer cell death
Tesniere, A., Panaretakis, T., Kepp, O., Apetoh, L., Ghiringhelli, F., Zitvogel, L., & Kroemer, G. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402269 · Cited by 494
Gershon, R. K., Cohen, P., Hencin, R., & Liebhaber, S. A. (1972) · The Journal of Immunology · doi:10.4049/jimmunol.108.3.586 · Cited by 459
How C-type lectins detect pathogens: C-type lectins and pathogens
Cambi, A., Koopman, M., & Figdor, C. G. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00506.x · Cited by 448
Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., & Vile, R. G. (1998) · Nature Medicine · doi:10.1038/nm0598-581 · Cited by 445
Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., & Boon, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7976 · Cited by 423
Photodynamic Action and Diseases Caused by Light
(1941) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1941.02820330079041 · Cited by 420
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Zitvogel, L., Kepp, O., Senovilla, L., Menger, L., Chaput, N., & Kroemer, G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2891 · Cited by 387
Intracellular signaling mechanisms in photodynamic therapy
Almeida, R. D., Manadas, B. J., Carvalho, A. P., & Duarte, C. B. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.05.003 · Cited by 379
Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function
Tang, Q., Boden, E. K., Henriksen, K. J., Bour‐Jordan, H., Bi, M., & Bluestone, J. A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425143 · Cited by 377
Berendt, M. J., & North, R. J. (1980) · The Journal of experimental medicine · doi:10.1084/jem.151.1.69 · Cited by 369
CD25− T Cells Generate CD25+Foxp3+ Regulatory T Cells by Peripheral Expansion
Curotto de Lafaille, M. A., Lino, A. C., Kutchukhidze, N., & Lafaille, J. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7259 · Cited by 368
Imbalance of regulatory T cells in human autoimmune diseases
Dejaco, C., Duftner, C., Grubeck‐Loebenstein, B., & Schirmer, M. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02317.x · Cited by 368
An outline of the hundred-year history of PDT.
Moan, J. E., & Peng, Q. (2004) · PubMed · Cited by 353
Role of cytokines in photodynamic therapy-induced local and systemic inflammation
Gollnick, S. O., Evans, S. S., Baumann, H., Owczarczak, B., Maier, P., Vaughan, L., Wang, W. C., Unger, E., & Henderson, B. W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600864 · Cited by 348
Rollinghoff, M., Starzinski-Powitz, A., Pfizenmaier, K., & Wagner, H. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.145.2.455 · Cited by 335
Todryk, S., Melcher, A. A., Hardwick, N., Linardakis, E., Bateman, A., Colombo, M. P., Stoppacciaro, A., & Vile, R. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1398 · Cited by 328
Antiapoptotic and Anti‐inflammatory Mechanisms of Heat‐Shock Protein Protection
YENARI, M. A., LIU, J., ZHENG, Z., VEXLER, Z. S., LEE, J. E., & GIFFARD, R. G. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00012.x · Cited by 299
Van den Eynde, B., Lethé, B., Van Pel, A., De Plaen, E., & Boon, T. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1373 · Cited by 298
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
Garg, A. D., Nowis, D., Golab, J., & Agostinis, P. (2010) · Apoptosis · doi:10.1007/s10495-010-0479-7 · Cited by 297
Chemotherapy induces ATP release from tumor cells
Martins, I., Tesniere, A., Kepp, O., Michaud, M., Schlemmer, F., Senovilla, L., Séror, C., Métivier, D., Perfettini, J.-L., Zitvogel, L., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.22.10026 · Cited by 278
Donato, R. (2007) · Current Molecular Medicine · doi:10.2174/156652407783220688 · Cited by 276
Korbelik, M., Sun, J., & Cecic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.1018.65.3 · Cited by 273
Regulatory T cells in immune surveillance and treatment of cancer
Yamaguchi, T., & Sakaguchi, S. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.11.005 · Cited by 263
Henderson, B. W., Gollnick, S. O., Snyder, J. W., Busch, T. M., Kousis, P. C., Cheney, R. T., & Morgan, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3513 · Cited by 263
Induction of Tumor Immunity by Photodynamic Therapy
KORBELIK, M. (1996) · Journal of Clinical Laser Medicine & Surgery · doi:10.1089/clm.1996.14.329 · Cited by 256
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma
Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., & Eisenbach, L. (1994) · Nature · doi:10.1038/369067a0 · Cited by 254
Toll-like receptors: a family of pattern-recognition receptors in mammals.
Armant, M. A., & Fenton, M. J. (2002) · Genome biology · doi:10.1186/gb-2002-3-8-reviews3011 · Cited by 246
How do CD4+CD25+ regulatory T cells control autoimmunity?
Bluestone, J. A., & Tang, Q. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.09.002 · Cited by 245
Generation of effective antitumor vaccines using photodynamic therapy.
Gollnick, S. O., Vaughan, L. A., & Henderson, B. W. (2002) · PubMed · Cited by 242
A unique tumor antigen produced by a single amino acid substitution
Monach, P. A., Meredith, S. C., T.Siegel, C., & Schreiber, H. (1995) · Immunity · doi:10.1016/1074-7613(95)90078-0 · Cited by 241
Wang, M., Bronte, V, Chen, P. W., Gritz, L., Panicali, D., Rosenberg, S. A., & Restifo, N. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4685 · Cited by 230
Photodynamic Therapy Enhancement of Antitumor Immunity Is Regulated by Neutrophils
Kousis, P. C., Henderson, B. W., Maier, P. G., & Gollnick, S. O. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1778 · Cited by 224
Krosl, G., Korbelik, M., & Dougherty, G. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.108 · Cited by 219
Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
Korbelik, M., & Dougherty, G. J. (1999) · PubMed · Cited by 211
PDT‐associated host response and its role in the therapy outcome
Korbelik, M. (2006) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20337 · Cited by 206
CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2
Antony, P. A., & Restifo, N. P. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000155049.26787.45 · Cited by 205
ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy
Robey, R. W., Steadman, K., Polgar, O., & Bates, S. E. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1440 · Cited by 204
Immunogenic cell death modalities and their impact on cancer treatment
Kepp, O., Tesniere, A., Schlemmer, F., Michaud, M., Senovilla, L., Zitvogel, L., & Kroemer, G. (2009) · Apoptosis · doi:10.1007/s10495-008-0303-9 · Cited by 204
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
Castano, A. P., Mroz, P., Wu, M. X., & Hamblin, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709256105 · Cited by 201
Self-citationApoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo
Scheffer, S. R., Nave, H., Korangy, F., Schlote, K., Pabst, R., Jaffee, E. M., Manns, M. P., & Greten, T. F. (2003) · International Journal of Cancer · doi:10.1002/ijc.10777 · Cited by 201
Abdel‐Hady, E., Martin‐Hirsch, P. L., Duggan-Keen, M. F., Stern, P. L., Moore, J., Corbitt, G., Kitchener, H. C., & HAMPSON, I. N. (2001) · PubMed · Cited by 192
Goldszmid, R. S., Idoyaga, J., Bravo, A. I., Steinman, R., Mordoh, J., & Wainstok, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5940 · Cited by 187
Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins.
Gomer, C. J., Ryter, S. W., Ferrario, A., Rucker, N., Wong, S., & Fisher, A. M. (1996) · PubMed · Cited by 172
Effect of Photodynamic Therapy on Tumor Necrosis Factor Production by Murine Macrophages
Evans, S., Matthews, W., Perry, R., Fraker, D., Norton, J., & Pass, H. I. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.34 · Cited by 167
The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy.
Korbelik, M., Krosl, G., Krošl, J., & Dougherty, G. J. (1996) · PubMed · Cited by 165
C-type lectins on dendritic cells: key modulators for the induction of immune responses
van Kooyk, Y. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361478 · Cited by 159
Recent Advances in Dendritic Cell Biology
Adams, S., O’Neill, D. W., & Bhardwaj, N. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-2814-2 · Cited by 152
Modulation of Dendritic Cell Function by Naive and Regulatory CD4+ T Cells1
Veldhoen, M., Moncrieffe, H., Hocking, R. J., Atkins, C., & Stockinger, B. (2006) · Journal of Immunology · doi:10.4049/jimmunol.176.10.6202 · Cited by 152
Kabingu, E., Vaughan, L. A., Owczarczak, B., Ramsey, K. D., & Gollnick, S. O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603792 · Cited by 151
Dubey, P., Hendrickson, R. C., Meredith, S. C., Siegel, C., Shabanowitz, J., Skipper, J., Engelhard, V. H., Hunt, D. F., & Schreiber, H. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.695 · Cited by 143
Thong, P. S. P., Ong, K.-W., Goh, N. S.-G., Kho, K.-W., Manivasager, V., Ramaswamy, B., Olivo, M., & Soo, K. C. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70318-2 · Cited by 140
Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo.
de Vree, W. J. A., Essers, M., de Bruijn, H. S., Star, W., Koster, J. F., & Sluiter, W. J. (1996) · PubMed · Cited by 136
Kabingu, E., Oseroff, A. R., Wilding, G. E., & Gollnick, S. O. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0400 · Cited by 132
Marzo, A. L., Lake, R., Robinson, B. W. S., & Scott, B. (1999) · PubMed · Cited by 122
Glaser, M. (1979) · The Journal of Experimental Medicine · doi:10.1084/jem.149.3.774 · Cited by 119
Photodynamic therapy-generated vaccine for cancer therapy
Korbelik, M., & Sun, J. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0088-4 · Cited by 117
Scotto, L., Naiyer, A. J., Galluzzo, S., Rossi, P. C., Manavalan, J. S., Kim‐Schulze, S., Fang, J., Favera, R. D., Cortesini, R., & Suciu‐Foca, N. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.09.004 · Cited by 117
Horino, K., Nishiura, H., Ohsako, T., Shibuya, Y., Hiraoka, T., Kitamura, N., & Yamamoto, T. (1998) · PubMed · Cited by 117
Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors
Cecić, I., & Korbelik, M. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00092-7 · Cited by 115
Apoptosis or necrosis for tumor immunotherapy: what's in a name?
Melcher, A. A., Gough, M. J., Todryk, S. M., & Vile, R. G. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900066 · Cited by 114
Cantl, G., Lattuada, D., Nicolin, A., Taroni, P., Valentinl, G., & Cubeddu, R. (1994) · Anti-Cancer Drugs · doi:10.1097/00001813-199408000-00009 · Cited by 110
In vivo sites and cellular mechanisms of T reg cell–mediated suppression
Rudensky, A. Y., & Campbell, D. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060214 · Cited by 108
Albers, A. E., Ferris, R. L., Kim, G. G., Chikamatsu, K., DeLeo, A. B., & Whiteside, T. L. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0670-9 · Cited by 105
Sun, J., Cecić, I., Parkins, C. S., & Korbelik, M. (2002) · Photochemical & Photobiological Sciences · doi:10.1039/b204254a · Cited by 102
How much will Herceptin really cost?
Barrett, A., Roques, T. W., Small, M., & Smith, R. (2006) · BMJ · doi:10.1136/bmj.39008.624051.be · Cited by 101
Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer
Korbelik, M., Naraparaju, V. R., & Yamamoto, N. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.34 · Cited by 96
Winters, U., Daayana, S., Lear, J. T., Tomlinson, A., Elkord, E., Stern, P. L., & Kitchener, H. C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4760 · Cited by 95
Loeffler, M. W., Krüger, J. A., & Reisfeld, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0646 · Cited by 88
Induction of Systemic Neutrophil Response in Mice by Photodynamic Therapy of Solid Tumors¶
Cecić, I., Parkins, C. S., & Korbelik, M. (2001) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2001)0740712iosnri2.0.co2 · Cited by 83
Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy
Xue, L., Chiu, S., & Oleinick, N. L. (2010) · Autophagy · doi:10.4161/auto.6.2.11077 · Cited by 81
Pan-Vertebrate Toll-Like Receptors During Evolution
Oshiumi, H., Matsuo, A., Matsumoto, M., & Seya, T. (2008) · Current Genomics · doi:10.2174/138920208786241234 · Cited by 76
Adverse effects of the humanized antibodies used as cancer therapeutics
Klastersky, J. A. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000228734.32261.62 · Cited by 75
Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy
Stott, B., & Korbelik, M. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0221-z · Cited by 75
Muzio, M., & Mantovani, A. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00303-8 · Cited by 74
Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulin
Korbelik, M., & Cooper, P. D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603508 · Cited by 73
ENHANCED MACROPHAGE CYTOTOXICITY AGAINST TUMOR CELLS TREATED WITH PHOTODYNAMIC THERAPY
Korbelik, M., & Krosl, G. (1994) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1994.tb05140.x · Cited by 72
Špíšek, R., & Dhodapkar, M. V. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4601 · Cited by 72
Krosl, G., Korbelik, M., Krošl, J., & Dougherty, G. J. (1996) · PubMed · Cited by 70
Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant
Chen, W. R., Korbelik, M., Bartels, K. E., Liu, H., Sun, J., & Nordquist, R. E. (2004) · Photochemistry and Photobiology · doi:10.1562/2004-07-20-ra-236 · Cited by 69
Chemokine Receptors as Targets for Cancer Therapy
Wu, X., Lee, V. C., Chevalier, É., & Hwang, S. T. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787582165 · Cited by 67
Simon, R. M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.09.009 · Cited by 65
Castaño, A. P., Liu, Q., & Hamblin, M. R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602953 · Cited by 64
Self-citationCecić, I., Stott, B., & Korbelik, M. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.008 · Cited by 64
Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG)
Krosl, G., & Korbelik, M. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90356-5 · Cited by 64
Mechanism of Drug Sensitivity and Resistance in Melanoma
Porta, C. A. M. L. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166574 · Cited by 62
Xue, L., Chiu, S., Azizuddin, K., Joseph, S. M., & Oleinick, N. L. (2007) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00159.x · Cited by 60
Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment
Korbelik, M., & Cecić, I. (1998) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(98)00138-9 · Cited by 58
Inflammation and cancer: a multifaceted link.
Sgambato, A., & Cittadini, A. (2010) · PubMed · Cited by 58
Gołąb, J., Wilczynski, G. M., Zagożdżon, R., Stokłosa, T., Dąbrowska, A., Rybczyńska, J., Wasik, M. A., Machaj, E. K., Ołdak, T., Kozar, K., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1078 · Cited by 57
Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α
Bellnier, D. A. (1991) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/1011-1344(91)80060-u · Cited by 57
Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1
Kessel, D. H., & Reiners, J. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.09.009 · Cited by 55
Hendrzak‐Henion, J. A., Knisely, T. L., Cincotta, L., Cincotta, E., & Cincotta, A. H. (1999) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1999.tb03330.x · Cited by 55
Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy
Volanti, C., Gloire, G., Vanderplasschen, A. F. C., Jacobs, N., Habraken, Y., & Piette, J. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207871 · Cited by 53
Korbelik, M., Sun, J., & Posakony, J. (2001) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2001)0730403ibptab2.0.co2 · Cited by 51
Yamamoto, N., Homma, S., Sery, T. W., Donoso, L. A., & Hoober, J. K. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90388-t · Cited by 49
McCabe, B. J., Irvine, K. R., Nishimura, M. I., Yang, J. C.-H., Spiess, P. J., Shulman, E., Rosenberg, S. A., & Restifo, N. P. (1995) · PubMed · Cited by 49
Korbelik, M., Sun, J., Cecić, I., & Serrano, K. (2004) · Photochemical & Photobiological Sciences · doi:10.1039/b315663j · Cited by 45
Enhancement of Laser Cancer Treatment by a Chitosan-derived Immunoadjuvant¶
Chen, W. R., Korbelik, M., Bartels, K. E., Liu, H., Sun, J., & Nordquist, R. E. (2005) · Photochemistry and Photobiology · doi:10.1562/2004-07-20-ra-236.1 · Cited by 45
Korbelik, M., & Cecić, I. (2008) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2008.04.005 · Cited by 43
The immune response against dying tumor cells: avoid disaster, achieve cure
Zitvogel, L., & Kroemer, G. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402267 · Cited by 40
The resistance phenotype in the development and treatment of cancer
Laconi, E., Pani, P., & Farber, E. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00154-6 · Cited by 39
Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro
de Vree, W. J. A., Fontijne-Dorsman, A., Koster, J. F., & Sluiter, W. J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.255 · Cited by 36
Myers, R. C., Lau, B. H. S., Kunihira, D. Y., Torrey, R. R., Woolley, J. L., & Tosk, J. (1989) · Urology · doi:10.1016/0090-4295(89)90399-3 · Cited by 35
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response
Mróz, P., & Hamblin, M. R. (2011) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2011.03.031 · Cited by 33
Self-citationUehara, M., Sano, K., Wang, Z., Sekine, J., Ikeda, H., & Inokuchi, T. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000134 · Cited by 30
Vaccine Prevention of Cancer: Can Endogenous Antigens Be Targeted?
Weiner, L. M., Surana, R., & Murray, J. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0040 · Cited by 29
de Bruijn, H. S., Sluiter, W. J., den Heuvel, A. V. D. P., Sterenborg, H. J. C. M., & Robinson, D. J. (2006) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2006.00240.x · Cited by 28
Seshadri, M., & Bellnier, D. A. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00395.x · Cited by 23
Sluiter, W. J., de Vree, W. J. A., Pietersma, A., & Koster, J. F. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00227904 · Cited by 19
Anti-tumor immunity generated by photodynamic therapy in a metastatic murine tumor model
Castaño, A. P., & Hamblin, M. R. (2005) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.589340 · Cited by 6
Self-citationEnhancing photodynamic therapy of a metastatic mouse breast cancer by immune stimulation
Castaño, A. P., & Hamblin, M. R. (2006) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.646242 · Cited by 4
Self-citation
Cited by
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Monro, S., Colón, K. L., Yin, H., Roque, J., Konda, P., Gujar, S., Thummel, R. P., Lilge, L., Cameron, C. G., & McFarland, S. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00211 · Cited by 1,461
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
Van Straten, D., Mashayekhi, V., De Bruijn, H., Oliveira, S., & Robinson, D. (2017) · Cancers · doi:10.3390/cancers9020019 · Cited by 1,012
He, C., Duan, X., Guo, N., Chan, C., Poon, C., Weichselbaum, R. R., & Lin, W. (2016) · Nature Communications · doi:10.1038/ncomms12499 · Cited by 754
Metadata
- Authors
- Mroz, P., Hashmi, J. T., Huang, Y.-Y., Lange, N., & Hamblin, M. R.
- Venue
- Expert Review of Clinical Immunology
- Publisher
- Informa UK Limited
- Published
- 2011-01
- Volume
- 7
- Issue
- 1
- Pages
- 75-91
- ISSN
- 1744-666X (ISSN-L)
- 1744-8409
- OpenAlex
- W2020344052
- Cited by
- 261
- References
- 151
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.